文献速递美容整形

面除皱术中局部注射氨甲环酸提高手术室效率:一项匹配患者研究

Local Infiltration of Tranexamic Acid During Facelift Improves Operating Room Efficiency: A Matched Patient Study.
PubMed 文献 · Aesthet Surg J · 2022-01-01

一项回顾性、单术者病例对照研究纳入2016年7月至2021年10月145例面除皱术患者,比较皮下注射含或不含氨甲环酸(TXA)的利多卡因/肾上腺素后的手术时间与并发症。无TXA组平均手术时间比TXA组延长21分钟(P=0.016);两组轻微并发症率无显著差异,均无重大并发症。

要点

  • 无TXA组平均手术时间较TXA组延长21分钟(P=0.016)。
  • 无TXA组6例(8%)出现轻微并发症,TXA组8例(11%),差异无统计学意义(P=0.56)。
  • 两组均无患者发生重大并发症。

核心结论

  • 本报告通过记录手术室节省的时间且未增加手术并发症,为TXA在面部美容手术中的应用增添了客观证据。

研究设计与样本

  • 回顾性、单术者病例对照研究,时间范围为2016年7月至2021年10月。
  • 共纳入145例连续患者,均接受单纯面除皱术或联合脂肪移植及口周化学剥脱术。
  • 所有患者接受0.5%利多卡因/1:200,000肾上腺素的皮下注射,含或不含1或2 mg/mL TXA。

主要发现

  • 共145例连续患者:第1组(无TXA)73例,第2组(TXA)72例。
  • 无TXA组平均手术时间比TXA组延长21分钟(P=0.016)。
  • 无TXA组6例(8%)发生轻微并发症,TXA组8例(11%),两组轻微并发症率无显著差异(P=0.56)。
  • 两组均无患者发生重大并发症。

关键数值与推荐

  • 性别分布P=0.75,年龄P=0.54,BMI P=0.18,二次除皱术频率P=0.08,辅助脂肪移植率P=0.44,TXA剂量P=0.238,轻微并发症率P=0.56。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) has rapidly gained popularity in aesthetic surgery. Previous reports have suggested that TXA provides a dry surgical field and significantly reduces operating time during facelift surgery. OBJECTIVES: The aim of this study was to build upon earlier findings by providing a large cohort matched alongside historic controls and more clearly document time saved when performing facelift surgery. METHODS: A retrospective, single-surgeon case-control study was undertaken between July 2016 and October 2021. All patients underwent facelift surgery alone or in combination with fat transfer and perioral chemical peel. All patients received subcutaneous infiltration of 0.5% lidocaine/1:200,000 epinephrine with or without 1 or 2 mg/mL TXA. Patient demographics, TXA dose, surgical time, and minor and major complications were examined. RESULTS: In total 145 consecutive patients were identified: 73 in Group 1 (no-TXA) and 72 in Group 2 (TXA). No differences in terms of gender distribution (P = 0.75), age (P = 0.54), BMI (P = 0.18), frequency of secondary rhytidectomy (P = 0.08), rate of ancillary lipografting (P = 0.44), TXA dose (P = 0.238), and minor complication rate (P = 0.56) were observed. However, mean surgical time in the no-TXA group was 21 minutes longer than in the TXA group (P = 0.016). Six patients (8%) in the no-TXA group experienced minor complications vs 8 patients (11%) in the TXA group. No patients experienced major complications. CONCLUSIONS: Although previous studies have highlighted the potential benefits of TXA in aesthetic surgery, most of the data remain subjective and non-validated. This report adds to the objective body of evidence supporting TXA in facial aesthetic surgery by documenting time saved in the operating room without additional surgical morbidity.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Coombs DM, Kwiecien GJ, Sinclair NR, et al. Local Infiltration of Tranexamic Acid During Facelift Improves Operating Room Efficiency: A Matched Patient Study. Aesthet Surg J. 2022. PMID: 35350068. doi:10.1093/asj/sjac067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。